Article info

Download PDFPDF

Response to: ‘Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al
Free

Authors

  1. Correspondence to Dr Pierre-Marie Duret, Service de Rhumatologie, Hôpitaux Civils de Colmar, Colmar 68024, France; pierremarie.duret{at}gmail.com
View Full Text

Citation

Duret P, Spielmann L, Messer L
Response to: ‘Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al

Publication history

  • Received August 2, 2020
  • Accepted August 3, 2020
  • First published August 18, 2020.
Online issue publication 
April 12, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.